Notably, PNOC expression in B cells has been previously identified within the tumor microenvironment of cholangiocarcinoma, where it is associated with increased immune infiltration and positively correlated with improved patient survival outcomes. The gene discussed is PNOC; the disease is cholangiocarcinoma.